BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Prognosis
6 results:

  • 1. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
    Lax SF
    Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Therapy-related myelodysplasia and acute myeloid leukemia.
    Bhatia S
    Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.
    Ben-Yehuda D; Krichevsky S; Caspi O; Rund D; Polliack A; Abeliovich D; Zelig O; Yahalom V; Paltiel O; Or R; Peretz T; Ben-Neriah S; Yehuda O; Rachmilewitz EA
    Blood; 1996 Dec; 88(11):4296-303. PubMed ID: 8943866
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment.
    van Leeuwen FE
    Baillieres Clin Haematol; 1996 Mar; 9(1):57-85. PubMed ID: 8730551
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.